首页 > 最新文献

International journal of clinical and experimental pathology最新文献

英文 中文
Recurrent plasma cell myeloma with intracytoplasmic Auer rod-like inclusions after autologous hematopoietic stem cell transplantation. 自体造血干细胞移植后复发性浆细胞骨髓瘤伴胞浆内奥尔棒样包涵体。
IF 0.9 Q4 ONCOLOGY Pub Date : 2025-09-15 eCollection Date: 2025-01-01 DOI: 10.62347/OLMG7236
Chenchen Niu, Elizabeth Brem, Ying Zhang, Dong Ren, Truc Tran, Ashley Gamayo, Xiaohui Zhao, Sherif A Rezk

Plasma cell myeloma (PCM) is a bone marrow based neoplastic disorder of plasma cells. The presence of intracytoplasmic Auer rod-like inclusions (ARLIs) in PCM is exceedingly rare. To the best of our knowledge, approximately 40 cases have been published since its first description in 1940. These inclusions are predominantly observed in kappa-restricted, IgG-producing PCM. Only 7 cases of kappa-restricted, IgA-producing PCM with intracytoplasmic ARLIs have been documented in the literature. Here, we reported a rare case of recurrent kappa-restricted, IgA-positive PCM exhibiting intracytoplasmic ARLIs both before and after autologous hematopoietic stem cell transplantation (HSCT). The clinical features, laboratory studies, diagnosis, and management of this case were described. A comprehensive review of the literature was also provided to explore the origin and pathogenesis of these inclusions, and to examine their prognostic implications.

浆细胞骨髓瘤是一种以骨髓为基础的浆细胞肿瘤疾病。在PCM中出现胞浆内奥尔棒样包涵体(ARLIs)是非常罕见的。据我们所知,自1940年首次描述以来,已经发表了大约40例病例。这些包涵体主要在kappa受限的、产生igg的PCM中观察到。文献中仅记录了7例kappa受限、产生iga的PCM伴胞浆内aris。在此,我们报告了一例罕见的复发性kappa限制性iga阳性PCM,在自体造血干细胞移植(HSCT)前后均表现为胞浆内aris。本文描述了该病例的临床特征、实验室研究、诊断和处理。我们还对文献进行了全面的回顾,以探讨这些包涵体的起源和发病机制,并检查其预后意义。
{"title":"Recurrent plasma cell myeloma with intracytoplasmic Auer rod-like inclusions after autologous hematopoietic stem cell transplantation.","authors":"Chenchen Niu, Elizabeth Brem, Ying Zhang, Dong Ren, Truc Tran, Ashley Gamayo, Xiaohui Zhao, Sherif A Rezk","doi":"10.62347/OLMG7236","DOIUrl":"10.62347/OLMG7236","url":null,"abstract":"<p><p>Plasma cell myeloma (PCM) is a bone marrow based neoplastic disorder of plasma cells. The presence of intracytoplasmic Auer rod-like inclusions (ARLIs) in PCM is exceedingly rare. To the best of our knowledge, approximately 40 cases have been published since its first description in 1940. These inclusions are predominantly observed in kappa-restricted, IgG-producing PCM. Only 7 cases of kappa-restricted, IgA-producing PCM with intracytoplasmic ARLIs have been documented in the literature. Here, we reported a rare case of recurrent kappa-restricted, IgA-positive PCM exhibiting intracytoplasmic ARLIs both before and after autologous hematopoietic stem cell transplantation (HSCT). The clinical features, laboratory studies, diagnosis, and management of this case were described. A comprehensive review of the literature was also provided to explore the origin and pathogenesis of these inclusions, and to examine their prognostic implications.</p>","PeriodicalId":13943,"journal":{"name":"International journal of clinical and experimental pathology","volume":"18 9","pages":"503-508"},"PeriodicalIF":0.9,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LncRNA CRNDE regulates the differentiation of tendon-derived stem cells and enhances rotator cuff injury repair by modulating the miR-337/TGFBR2 axis. LncRNA CRNDE通过调节miR-337/TGFBR2轴调控肌腱源性干细胞的分化并增强肩袖损伤修复。
IF 0.9 Q4 ONCOLOGY Pub Date : 2025-09-15 eCollection Date: 2025-01-01 DOI: 10.62347/ZVJT6300
Hanyin Lin, Yiyong Tang, Wei Xiang, Lu Liu, Yanyan Zhou, Qisheng Lin

The differentiation of stem cells into tendon cells plays a crucial role in the repair of rotator cuff injuries. Long non-coding RNAs (lncRNAs) are known to regulate tendon-derived stem cell (TDSC) differentiation during tendon injury; however, the specific mechanisms involving the lncRNA colorectal neoplasia differentially expressed (CRNDE) have not been fully elucidated. In this study, we successfully isolated and cultured TDSCs, and established a tenogenic differentiation model through ascorbic acid treatment. RNA sequencing analysis showed that ascorbic acid significantly upregulated CRNDE expression. Furthermore, CRNDE overexpression in TDSCs markedly enhanced tenogenic differentiation. Using bioinformatics analysis in combination with luciferase reporter assays, we demonstrated that CRNDE and transforming growth factor beta receptor 2 (TGFBR2) contain shared binding sequences for miR-337, suggesting a competitive regulatory interaction. Overexpression of miR-337 was found to inhibit CRNDE-induced tenogenic differentiation and reduce both TGFBR2 mRNA and protein levels. In contrast, CRNDE knockdown decreased TGFBR2 protein expression and impaired tenogenic differentiation of TDSCs. In a rat model of rotator cuff tear (RCT), transplantation of CRNDE-overexpressing TDSCs significantly enhanced functional recovery, an effect associated with upregulation of TGFBR2. Taken together, these results demonstrate that CRNDE promotes tenogenic differentiation and tendon-bone healing through modulation of the miR-337/TGFBR2 signaling axis.

干细胞向肌腱细胞的分化在肌腱套损伤的修复中起着至关重要的作用。已知长链非编码rna (lncRNAs)在肌腱损伤期间调节肌腱源性干细胞(TDSC)的分化;然而,lncRNA结直肠癌差异表达(CRNDE)的具体机制尚未完全阐明。本研究成功分离培养了tdsc,并通过抗坏血酸处理建立了成腱鞘分化模型。RNA测序分析显示,抗坏血酸显著上调CRNDE的表达。此外,CRNDE在tdsc中的过表达显著增强了成腱鞘分化。利用生物信息学分析结合荧光素酶报告基因检测,我们证明了CRNDE和转化生长因子β受体2 (TGFBR2)含有miR-337的共享结合序列,表明它们之间存在竞争性调控相互作用。研究发现,过表达miR-337可抑制crnde诱导的肌腱分化,降低TGFBR2 mRNA和蛋白水平。相反,CRNDE敲低可降低TGFBR2蛋白表达,并损害tdsc的成腱分化。在大鼠肩袖撕裂(RCT)模型中,移植过表达crnde的tdsc可显著增强功能恢复,这一效应与TGFBR2的上调有关。综上所述,这些结果表明CRNDE通过调节miR-337/TGFBR2信号轴促进肌腱分化和肌腱骨愈合。
{"title":"LncRNA CRNDE regulates the differentiation of tendon-derived stem cells and enhances rotator cuff injury repair by modulating the miR-337/TGFBR2 axis.","authors":"Hanyin Lin, Yiyong Tang, Wei Xiang, Lu Liu, Yanyan Zhou, Qisheng Lin","doi":"10.62347/ZVJT6300","DOIUrl":"10.62347/ZVJT6300","url":null,"abstract":"<p><p>The differentiation of stem cells into tendon cells plays a crucial role in the repair of rotator cuff injuries. Long non-coding RNAs (lncRNAs) are known to regulate tendon-derived stem cell (TDSC) differentiation during tendon injury; however, the specific mechanisms involving the lncRNA colorectal neoplasia differentially expressed (CRNDE) have not been fully elucidated. In this study, we successfully isolated and cultured TDSCs, and established a tenogenic differentiation model through ascorbic acid treatment. RNA sequencing analysis showed that ascorbic acid significantly upregulated CRNDE expression. Furthermore, CRNDE overexpression in TDSCs markedly enhanced tenogenic differentiation. Using bioinformatics analysis in combination with luciferase reporter assays, we demonstrated that CRNDE and transforming growth factor beta receptor 2 (TGFBR2) contain shared binding sequences for miR-337, suggesting a competitive regulatory interaction. Overexpression of miR-337 was found to inhibit CRNDE-induced tenogenic differentiation and reduce both TGFBR2 mRNA and protein levels. In contrast, CRNDE knockdown decreased TGFBR2 protein expression and impaired tenogenic differentiation of TDSCs. In a rat model of rotator cuff tear (RCT), transplantation of CRNDE-overexpressing TDSCs significantly enhanced functional recovery, an effect associated with upregulation of TGFBR2. Taken together, these results demonstrate that CRNDE promotes tenogenic differentiation and tendon-bone healing through modulation of the miR-337/TGFBR2 signaling axis.</p>","PeriodicalId":13943,"journal":{"name":"International journal of clinical and experimental pathology","volume":"18 9","pages":"481-493"},"PeriodicalIF":0.9,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531497/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145329084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the correlation between COL11A1 gene expression and clinical features in bladder urothelial carcinoma. COL11A1基因表达与膀胱尿路上皮癌临床特征的相关性分析。
IF 0.9 Q4 ONCOLOGY Pub Date : 2025-08-15 eCollection Date: 2025-01-01 DOI: 10.62347/UVYA4792
Jun Li, Fang Wang, Xiaoyong Wei, Peipei Li, Qin Wang, Hongxing Min

Bladder urothelial carcinoma (BLCA) is a prevalent urinary malignancy that complicates diagnosis and treatment. This study investigates the diagnostic and prognostic utility of COL11A1, a gene implicated in tumor progression and immune modulation, by analyzing its association with clinicopathological features, tumor progression, and immune infiltration dynamics. Using statistical methods, including Kaplan-Meier survival analysis and immune infiltration profiling, we evaluated COL11A1 expression in 407 BLCA patients and 28 normal controls. Results demonstrated significant COL11A1 overexpression in BLCA tissues versus controls (P < 0.001), with elevated expression correlating with poorer survival outcomes (hazard ratio = 1.53, P = 0.005). Immune infiltration analysis revealed robust positive associations between COL11A1 levels and macrophages, Th1 cells, natural killer (NK) cells, and neutrophils (P < 0.001), alongside significant links to advanced T stage (P < 0.001) and N stage (P = 0.030). These findings establish COL11A1 as a multifaceted biomarker for BLCA, offering critical insights into diagnosis, prognosis, and therapeutic strategies. Further research should elucidate its mechanistic roles in tumorigenesis and immune regulation, with potential applications across malignancies to advance personalized oncology.

膀胱尿路上皮癌(BLCA)是一种常见的泌尿系统恶性肿瘤,其诊断和治疗都很复杂。本研究通过分析COL11A1基因与临床病理特征、肿瘤进展和免疫浸润动力学的关系,探讨了COL11A1基因在肿瘤进展和免疫调节中的诊断和预后作用。采用Kaplan-Meier生存分析和免疫浸润分析等统计方法,我们对407例BLCA患者和28例正常对照的COL11A1表达进行了评估。结果显示,与对照组相比,BLCA组织中COL11A1过表达显著(P < 0.001),表达升高与较差的生存结果相关(风险比= 1.53,P = 0.005)。免疫浸润分析显示COL11A1水平与巨噬细胞、Th1细胞、自然杀伤(NK)细胞和中性粒细胞之间存在显著正相关(P < 0.001),与晚期T期(P < 0.001)和N期(P = 0.030)也存在显著正相关。这些发现确立了COL11A1作为BLCA的多方面生物标志物,为BLCA的诊断、预后和治疗策略提供了重要的见解。进一步的研究应阐明其在肿瘤发生和免疫调节中的机制作用,并具有在恶性肿瘤中的潜在应用,以推进个性化肿瘤治疗。
{"title":"Analysis of the correlation between COL11A1 gene expression and clinical features in bladder urothelial carcinoma.","authors":"Jun Li, Fang Wang, Xiaoyong Wei, Peipei Li, Qin Wang, Hongxing Min","doi":"10.62347/UVYA4792","DOIUrl":"10.62347/UVYA4792","url":null,"abstract":"<p><p>Bladder urothelial carcinoma (BLCA) is a prevalent urinary malignancy that complicates diagnosis and treatment. This study investigates the diagnostic and prognostic utility of COL11A1, a gene implicated in tumor progression and immune modulation, by analyzing its association with clinicopathological features, tumor progression, and immune infiltration dynamics. Using statistical methods, including Kaplan-Meier survival analysis and immune infiltration profiling, we evaluated COL11A1 expression in 407 BLCA patients and 28 normal controls. Results demonstrated significant COL11A1 overexpression in BLCA tissues versus controls (P < 0.001), with elevated expression correlating with poorer survival outcomes (hazard ratio = 1.53, P = 0.005). Immune infiltration analysis revealed robust positive associations between COL11A1 levels and macrophages, Th1 cells, natural killer (NK) cells, and neutrophils (P < 0.001), alongside significant links to advanced T stage (P < 0.001) and N stage (P = 0.030). These findings establish COL11A1 as a multifaceted biomarker for BLCA, offering critical insights into diagnosis, prognosis, and therapeutic strategies. Further research should elucidate its mechanistic roles in tumorigenesis and immune regulation, with potential applications across malignancies to advance personalized oncology.</p>","PeriodicalId":13943,"journal":{"name":"International journal of clinical and experimental pathology","volume":"18 8","pages":"454-463"},"PeriodicalIF":0.9,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12438968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145080374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Up-regulated FSTL5 inhibits invasion of hepatocellular carcinoma through the Wnt/β-catenin/YAP pathway. 更正:上调FSTL5通过Wnt/β-catenin/YAP途径抑制肝癌的侵袭。
IF 0.9 Q4 ONCOLOGY Pub Date : 2025-08-15 eCollection Date: 2025-01-01 DOI: 10.62347/GBGY9274
Deng-Yong Zhang, Wan-Liang Sun, Xiang Ma, Pei Zhang, Wei Wu, Huan Wu, Shuo Zhou, Zheng Lu

[This corrects the article on p. 10325 in vol. 10, PMID: 31966367.].

[这更正了第10卷第10325页的文章,PMID: 31966367]。
{"title":"Erratum: Up-regulated FSTL5 inhibits invasion of hepatocellular carcinoma through the Wnt/β-catenin/YAP pathway.","authors":"Deng-Yong Zhang, Wan-Liang Sun, Xiang Ma, Pei Zhang, Wei Wu, Huan Wu, Shuo Zhou, Zheng Lu","doi":"10.62347/GBGY9274","DOIUrl":"https://doi.org/10.62347/GBGY9274","url":null,"abstract":"<p><p>[This corrects the article on p. 10325 in vol. 10, PMID: 31966367.].</p>","PeriodicalId":13943,"journal":{"name":"International journal of clinical and experimental pathology","volume":"18 8","pages":"478-480"},"PeriodicalIF":0.9,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12438969/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145080482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unraveling the genetic basis of metabolic traits and benign adrenal tumors: a comprehensive causal analysis. 揭示代谢特征和良性肾上腺肿瘤的遗传基础:全面的因果分析。
IF 0.9 Q4 ONCOLOGY Pub Date : 2025-08-15 eCollection Date: 2025-01-01 DOI: 10.62347/NAFP6524
Junhao Chen, Xiangyun Li, Jieming Zuo, Yuanzhi Fu, Li Zhao, Jun Xie, Cheng Deng, Peiqin Zhan, Zhaojiao Li, Siwen Chen, Hongqiong Li, Yun Gong, Peng Chen, Junxian Zhao, Bo Chen, Haifeng Wang, Shi Fu

Objective: Cardiovascular and metabolic diseases, including both obesity and blood pressure, have been previously implicated in observational studies as having some association with the occurrence of adrenal tumors. This study aims to evaluate the causal relationships of these high-risk factors with the disease using a Mendelian randomization approach with two-sample data. Single nucleotide polymorphisms (SNPs) for blood pressure, body mass index (BMI), blood glucose, and cardiovascular diseases were extracted from publicly available whole-genome databases. They were then compared separately with benign adrenal tumors. It was found that only BMI was associated with the occurrence of benign adrenal tumors, and this process may be mediated by C-reactive protein (CRP). We explored whether C-reactive protein (CRP) can mediate the causal relationship between body mass index (BMI) and benign adrenal tumors, further investigating the mechanism and the proportion of CRP involved in this process.

Methods: Utilizing a two-sample Mendelian randomization approach, comparisons were made between BMI, blood pressure, cardiovascular diseases, blood glucose, and the outcome. Subsequently, both two-sample Mendelian randomization and multivariable Mendelian randomization (MVMR) analyses were conducted to investigate whether CRP serves as a mediator in the causal relationship between BMI and benign adrenal tumors, while calculating the proportion of mediation involved.

Results: There was no causal relationship observed between blood pressure (OR = 0.976, 95% CI = 0.931-1.024, P = 0.339), blood glucose (OR = 0.960, 95% CI = 0.648-1.422, P = 0.840), cardiovascular diseases (OR = 0.724, 95% CI = 0.244-2.142, P = 0.559), and benign adrenal tumors. However, a positive causal relationship was found between BMI and benign adrenal tumors (OR = 1.20, 95% CI = 1.06-1.35, P = 0.003). There was also a positive causal relationship observed between BMI and CRP (OR = 1.07, 95% CI = 1.06-1.08, P < 0.01), as well as between CRP and benign adrenal tumors (OR = 1.350, 95% CI = 1.058-1.722, P = 0.001). After adjusting for CRP, the causal relationship between BMI and benign adrenal tumors diminished (OR = 1.044, 95% CI = 0.911-1.970, P = 0.067). Even after controlling for BMI, a causal relationship between CRP and benign adrenal tumors persisted (OR = 1.32, 95% CI = 1.035-1.693, P = 0.025). The proportion of mediation by CRP was calculated to be 10.4%.

Conclusion: Using Mendelian genetic research methods, this study provides evidence that elevated levels of C-reactive protein may serve as a crucial mediating factor in BMI-induced benign adrenal tumors. Therefore, clinicians should pay particular attention to monitoring and managing levels of C-reactive protein when dealing with obese patients, to more effectively prevent the development of adrenal tumors.

目的:心血管和代谢疾病,包括肥胖和血压,在之前的观察性研究中被认为与肾上腺肿瘤的发生有一定的关联。本研究旨在评估这些高危因素与疾病的因果关系,采用孟德尔随机化方法与双样本数据。从公开的全基因组数据库中提取血压、体重指数(BMI)、血糖和心血管疾病的单核苷酸多态性(snp)。然后分别与良性肾上腺肿瘤进行比较。我们发现只有BMI与良性肾上腺肿瘤的发生有关,这一过程可能是由c反应蛋白(CRP)介导的。我们探讨c反应蛋白(CRP)是否可以介导身体质量指数(BMI)与良性肾上腺肿瘤的因果关系,进一步探讨CRP参与这一过程的机制和比例。方法:采用双样本孟德尔随机化方法,比较BMI、血压、心血管疾病、血糖和结局。随后,我们进行了双样本孟德尔随机化和多变量孟德尔随机化(MVMR)分析,以研究CRP是否在BMI与良性肾上腺肿瘤的因果关系中起中介作用,并计算中介所涉及的比例。结果:血压(OR = 0.976, 95% CI = 0.931-1.024, P = 0.339)、血糖(OR = 0.960, 95% CI = 0.648-1.422, P = 0.840)、心血管疾病(OR = 0.724, 95% CI = 0.244-2.142, P = 0.559)与肾上腺良性肿瘤无因果关系。BMI与肾上腺良性肿瘤呈正相关(OR = 1.20, 95% CI = 1.06-1.35, P = 0.003)。BMI与CRP呈正相关(OR = 1.07, 95% CI = 1.06 ~ 1.08, P < 0.01), CRP与肾上腺良性肿瘤呈正相关(OR = 1.350, 95% CI = 1.058 ~ 1.722, P = 0.001)。校正CRP后,BMI与肾上腺良性肿瘤的因果关系减弱(OR = 1.044, 95% CI = 0.911-1.970, P = 0.067)。即使在控制BMI后,CRP与良性肾上腺肿瘤之间的因果关系仍然存在(OR = 1.32, 95% CI = 1.035-1.693, P = 0.025)。计算出CRP介导的比例为10.4%。结论:本研究采用孟德尔遗传学研究方法,证明c反应蛋白水平升高可能是bmi诱发良性肾上腺肿瘤的重要介导因素。因此,临床医生在治疗肥胖患者时应特别注意监测和管理c反应蛋白水平,以更有效地预防肾上腺肿瘤的发生。
{"title":"Unraveling the genetic basis of metabolic traits and benign adrenal tumors: a comprehensive causal analysis.","authors":"Junhao Chen, Xiangyun Li, Jieming Zuo, Yuanzhi Fu, Li Zhao, Jun Xie, Cheng Deng, Peiqin Zhan, Zhaojiao Li, Siwen Chen, Hongqiong Li, Yun Gong, Peng Chen, Junxian Zhao, Bo Chen, Haifeng Wang, Shi Fu","doi":"10.62347/NAFP6524","DOIUrl":"10.62347/NAFP6524","url":null,"abstract":"<p><strong>Objective: </strong>Cardiovascular and metabolic diseases, including both obesity and blood pressure, have been previously implicated in observational studies as having some association with the occurrence of adrenal tumors. This study aims to evaluate the causal relationships of these high-risk factors with the disease using a Mendelian randomization approach with two-sample data. Single nucleotide polymorphisms (SNPs) for blood pressure, body mass index (BMI), blood glucose, and cardiovascular diseases were extracted from publicly available whole-genome databases. They were then compared separately with benign adrenal tumors. It was found that only BMI was associated with the occurrence of benign adrenal tumors, and this process may be mediated by C-reactive protein (CRP). We explored whether C-reactive protein (CRP) can mediate the causal relationship between body mass index (BMI) and benign adrenal tumors, further investigating the mechanism and the proportion of CRP involved in this process.</p><p><strong>Methods: </strong>Utilizing a two-sample Mendelian randomization approach, comparisons were made between BMI, blood pressure, cardiovascular diseases, blood glucose, and the outcome. Subsequently, both two-sample Mendelian randomization and multivariable Mendelian randomization (MVMR) analyses were conducted to investigate whether CRP serves as a mediator in the causal relationship between BMI and benign adrenal tumors, while calculating the proportion of mediation involved.</p><p><strong>Results: </strong>There was no causal relationship observed between blood pressure (OR = 0.976, 95% CI = 0.931-1.024, P = 0.339), blood glucose (OR = 0.960, 95% CI = 0.648-1.422, P = 0.840), cardiovascular diseases (OR = 0.724, 95% CI = 0.244-2.142, P = 0.559), and benign adrenal tumors. However, a positive causal relationship was found between BMI and benign adrenal tumors (OR = 1.20, 95% CI = 1.06-1.35, P = 0.003). There was also a positive causal relationship observed between BMI and CRP (OR = 1.07, 95% CI = 1.06-1.08, P < 0.01), as well as between CRP and benign adrenal tumors (OR = 1.350, 95% CI = 1.058-1.722, P = 0.001). After adjusting for CRP, the causal relationship between BMI and benign adrenal tumors diminished (OR = 1.044, 95% CI = 0.911-1.970, P = 0.067). Even after controlling for BMI, a causal relationship between CRP and benign adrenal tumors persisted (OR = 1.32, 95% CI = 1.035-1.693, P = 0.025). The proportion of mediation by CRP was calculated to be 10.4%.</p><p><strong>Conclusion: </strong>Using Mendelian genetic research methods, this study provides evidence that elevated levels of C-reactive protein may serve as a crucial mediating factor in BMI-induced benign adrenal tumors. Therefore, clinicians should pay particular attention to monitoring and managing levels of C-reactive protein when dealing with obese patients, to more effectively prevent the development of adrenal tumors.</p>","PeriodicalId":13943,"journal":{"name":"International journal of clinical and experimental pathology","volume":"18 8","pages":"426-438"},"PeriodicalIF":0.9,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12438970/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145080552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative evaluation of β-glucan functional dressing and interferon-α2a plug for vaginal microecology restoration and HPV clearance in women with bacterial vaginosis or aerobic vaginitis. β-葡聚糖功能敷料与干扰素-α2a塞对细菌性阴道病或需氧性阴道炎患者阴道微生态修复及HPV清除效果的比较评价
IF 0.9 Q4 ONCOLOGY Pub Date : 2025-08-15 eCollection Date: 2025-01-01 DOI: 10.62347/ZLJW5581
Yuyan Dong, Fang Han, Hui Zhang

Objective: To compare the effectiveness of β-glucan functional dressing and interferon-α2a (IFN-α2a) plug in promoting high-risk human papillomavirus (HR-HPV) clearance and restoring vaginal microecology in women with bacterial vaginosis (BV) or aerobic vaginitis (AV).

Methods: This prospective-retrospective study enrolled 44 women diagnosed with BV or AV. Participants were evaluated for vaginal ecological indicators including pH, cleanliness, hydrogen peroxide (H2O2), sialidase, leukocyte esterase (LE), microbial diversity, lactobacilli proportion, and standard diagnostic scores (Nugent and AV). HPV status and squamous intraepithelial lesion (SIL) grade were assessed via cytology and colposcopy. Subjects were randomly divided into Group A (n=22), treated with β-glucan dressing, and Group B (n=22), treated with IFN-α2a plug for 14 days (excluding menstruation). Clinical and virological parameters were re-evaluated after three months.

Results: Both groups were comparable at baseline. No adverse effects were reported. Post-treatment analysis showed that β-glucan dressing significantly improved markers of inflammation (LE, H2O2), increased lactobacilli abundance, and reduced pathogenic bacteria. IFN-α2a treatment improved vaginal pH and diagnostic scores but was less effective in microbiota restoration. The HPV-negative conversion rate was higher in the β-glucan group (87%) than that in the IFN-α2a group, and the difference was statistically significant (P<0.05).

Conclusion: Both β-glucan and IFN-α2a dressings were safe and showed clinical benefits in women with BV or AV and HR-HPV infection. However, β-glucan demonstrated superior outcomes in restoring vaginal microecology and enhancing HPV clearance. These findings suggest that β-glucan may serve as a more effective intravaginal immunomodulatory therapy. Further multicenter studies with larger samples are needed to confirm these results.

目的:比较β-葡聚糖功能换药与干扰素-α2a (IFN-α2a)塞在促进细菌性阴道病(BV)或需氧性阴道炎(AV)患者高危人乳头瘤病毒(HR-HPV)清除和恢复阴道微生态方面的效果。方法:这项前瞻性-回顾性研究纳入了44名诊断为BV或AV的女性。对参与者进行阴道生态指标评估,包括pH值、洁净度、过氧化氢(H2O2)、唾液酸酶、白细胞酯酶(LE)、微生物多样性、乳酸菌比例和标准诊断评分(Nugent和AV)。通过细胞学和阴道镜检查评估HPV状态和鳞状上皮内病变(SIL)等级。随机分为A组(n=22)和B组(n=22), A组采用β-葡聚糖敷料治疗,B组采用IFN-α2a堵塞治疗,疗程14 d(不含月经)。3个月后重新评估临床和病毒学参数。结果:两组在基线时具有可比性。无不良反应报告。治疗后分析显示,β-葡聚糖敷料显著改善炎症标志物(LE, H2O2),增加乳酸菌丰度,减少致病菌。IFN-α2a治疗改善了阴道pH值和诊断评分,但在微生物群恢复方面效果较差。β-葡聚糖组hpv阴性转换率(87%)高于IFN-α2a组,差异有统计学意义(p)结论:β-葡聚糖和IFN-α2a敷料对BV或AV合并HR-HPV感染的女性是安全的,且具有临床疗效。然而,β-葡聚糖在恢复阴道微生态和增强HPV清除方面表现出优越的结果。这些发现表明β-葡聚糖可能作为一种更有效的阴道内免疫调节疗法。需要更多的多中心研究来证实这些结果。
{"title":"Comparative evaluation of β-glucan functional dressing and interferon-α2a plug for vaginal microecology restoration and HPV clearance in women with bacterial vaginosis or aerobic vaginitis.","authors":"Yuyan Dong, Fang Han, Hui Zhang","doi":"10.62347/ZLJW5581","DOIUrl":"10.62347/ZLJW5581","url":null,"abstract":"<p><strong>Objective: </strong>To compare the effectiveness of β-glucan functional dressing and interferon-α2a (IFN-α2a) plug in promoting high-risk human papillomavirus (HR-HPV) clearance and restoring vaginal microecology in women with bacterial vaginosis (BV) or aerobic vaginitis (AV).</p><p><strong>Methods: </strong>This prospective-retrospective study enrolled 44 women diagnosed with BV or AV. Participants were evaluated for vaginal ecological indicators including pH, cleanliness, hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), sialidase, leukocyte esterase (LE), microbial diversity, lactobacilli proportion, and standard diagnostic scores (Nugent and AV). HPV status and squamous intraepithelial lesion (SIL) grade were assessed via cytology and colposcopy. Subjects were randomly divided into Group A (n=22), treated with β-glucan dressing, and Group B (n=22), treated with IFN-α2a plug for 14 days (excluding menstruation). Clinical and virological parameters were re-evaluated after three months.</p><p><strong>Results: </strong>Both groups were comparable at baseline. No adverse effects were reported. Post-treatment analysis showed that β-glucan dressing significantly improved markers of inflammation (LE, H<sub>2</sub>O<sub>2</sub>), increased lactobacilli abundance, and reduced pathogenic bacteria. IFN-α2a treatment improved vaginal pH and diagnostic scores but was less effective in microbiota restoration. The HPV-negative conversion rate was higher in the β-glucan group (87%) than that in the IFN-α2a group, and the difference was statistically significant (P<0.05).</p><p><strong>Conclusion: </strong>Both β-glucan and IFN-α2a dressings were safe and showed clinical benefits in women with BV or AV and HR-HPV infection. However, β-glucan demonstrated superior outcomes in restoring vaginal microecology and enhancing HPV clearance. These findings suggest that β-glucan may serve as a more effective intravaginal immunomodulatory therapy. Further multicenter studies with larger samples are needed to confirm these results.</p>","PeriodicalId":13943,"journal":{"name":"International journal of clinical and experimental pathology","volume":"18 8","pages":"414-425"},"PeriodicalIF":0.9,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12438972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145080509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of different ventilation modes on postoperative cognitive dysfunction in elderly patients undergoing laparoscopic abdominal wall herniorrhaphy. 不同通气方式对老年腹腔镜腹壁修补术患者术后认知功能障碍的影响。
IF 0.9 Q4 ONCOLOGY Pub Date : 2025-08-15 eCollection Date: 2025-01-01 DOI: 10.62347/ZTCE4798
Yu-Long Jia, Xiao-Yu Zhang, Chen-Xu Chou, Bo Chen, Xia-Guang Duan

Objective: To compare the effects of three ventilation modes - pressure-controlled ventilation (PC), volume-controlled ventilation (VC), and pressure-regulated volume control ventilation (PRVC) - on postoperative cognitive dysfunction (POCD) in elderly patients undergoing laparoscopic abdominal wall hernia repair.

Methods: In this prospective study, 485 elderly patients undergoing laparoscopic abdominal wall hernia repair were randomly assigned to one of three ventilation groups: PC, VC, or PRVC. Cognitive function was assessed using the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) at baseline (D0), and on postoperative days 1 (D1) and 3 (D3). Intraoperative physiological indicators, including mean arterial pressure (MAP), heart rate (HR), PaCO2, central venous pressure (CVP), dynamic lung compliance (Cdyn), and optic nerve sheath diameter (ONSD), were recorded at five perioperative time points (T1-T5). Plasma concentrations of brain injury biomarkers (Aβ1-40, S-100β) and inflammatory cytokines (IL-1β, IL-6, TNF-α) were measured at baseline and serial postoperative time points (TI-TV).

Results: The incidence of POCD differed significantly among the three ventilation groups on both postoperative day 1 (P = 0.040) and day 3 (P = 0.034). On day 3, post-hoc analysis revealed that the POCD rate in the PRVC group was significantly lower than in the PC group (P < 0.0167). Regarding potential mechanisms, PRVC was associated with improved dynamic lung compliance and a lower optic nerve sheath diameter compared to both PC and VC groups. Furthermore, PRVC significantly reduced plasma concentrations of the inflammatory cytokines IL-1β and IL-6 (all P < 0.05).

Conclusion: In elderly patients undergoing abdominal wall hernia repair, PRVC ventilation reduced the incidence of early POCD, particularly compared to PC ventilation. This neuroprotective effect appears to be linked to improved respiratory mechanics and an attenuated systemic inflammatory response. Therefore, PRVC represents a preferable ventilation strategy for this vulnerable patient population.

目的:比较压力控制通气(PC)、容积控制通气(VC)和压力调节容积控制通气(PRVC)三种通气方式对老年腹腔镜腹壁疝修补术患者术后认知功能障碍(POCD)的影响。方法:在这项前瞻性研究中,485例接受腹腔镜腹壁疝修补术的老年患者被随机分为三个通气组:PC、VC或PRVC。在基线(D0)、术后第1天(D1)和第3天(D3)使用简易精神状态检查(MMSE)和蒙特利尔认知评估(MoCA)评估认知功能。术中生理指标包括平均动脉压(MAP)、心率(HR)、PaCO2、中心静脉压(CVP)、动态肺顺应性(Cdyn)、视神经鞘直径(ONSD)等5个围手术期时间点(T1-T5)。在基线和术后连续时间点(TI-TV)测量脑损伤生物标志物(a - β1-40、S-100β)和炎症因子(IL-1β、IL-6、TNF-α)的血浆浓度。结果:3个通气组术后第1天(P = 0.040)和第3天(P = 0.034) POCD发生率均有显著差异。第3天,事后分析显示,PRVC组的POCD发生率显著低于PC组(P < 0.0167)。关于潜在的机制,与PC和VC组相比,PRVC与改善的动态肺顺应性和更低的视神经鞘直径有关。此外,PRVC显著降低了血浆中炎症因子IL-1β和IL-6的浓度(均P < 0.05)。结论:在行腹壁疝修补术的老年患者中,PRVC通气降低了早期POCD的发生率,特别是与PC通气相比。这种神经保护作用似乎与改善呼吸力学和减轻全身炎症反应有关。因此,对于这一弱势患者群体,PRVC是一种较好的通气策略。
{"title":"Effect of different ventilation modes on postoperative cognitive dysfunction in elderly patients undergoing laparoscopic abdominal wall herniorrhaphy.","authors":"Yu-Long Jia, Xiao-Yu Zhang, Chen-Xu Chou, Bo Chen, Xia-Guang Duan","doi":"10.62347/ZTCE4798","DOIUrl":"10.62347/ZTCE4798","url":null,"abstract":"<p><strong>Objective: </strong>To compare the effects of three ventilation modes - pressure-controlled ventilation (PC), volume-controlled ventilation (VC), and pressure-regulated volume control ventilation (PRVC) - on postoperative cognitive dysfunction (POCD) in elderly patients undergoing laparoscopic abdominal wall hernia repair.</p><p><strong>Methods: </strong>In this prospective study, 485 elderly patients undergoing laparoscopic abdominal wall hernia repair were randomly assigned to one of three ventilation groups: PC, VC, or PRVC. Cognitive function was assessed using the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) at baseline (D0), and on postoperative days 1 (D1) and 3 (D3). Intraoperative physiological indicators, including mean arterial pressure (MAP), heart rate (HR), PaCO<sub>2</sub>, central venous pressure (CVP), dynamic lung compliance (Cdyn), and optic nerve sheath diameter (ONSD), were recorded at five perioperative time points (T1-T5). Plasma concentrations of brain injury biomarkers (Aβ1-40, S-100β) and inflammatory cytokines (IL-1β, IL-6, TNF-α) were measured at baseline and serial postoperative time points (TI-TV).</p><p><strong>Results: </strong>The incidence of POCD differed significantly among the three ventilation groups on both postoperative day 1 (<i>P</i> = 0.040) and day 3 (<i>P</i> = 0.034). On day 3, post-hoc analysis revealed that the POCD rate in the PRVC group was significantly lower than in the PC group (<i>P</i> < 0.0167). Regarding potential mechanisms, PRVC was associated with improved dynamic lung compliance and a lower optic nerve sheath diameter compared to both PC and VC groups. Furthermore, PRVC significantly reduced plasma concentrations of the inflammatory cytokines IL-1β and IL-6 (all <i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>In elderly patients undergoing abdominal wall hernia repair, PRVC ventilation reduced the incidence of early POCD, particularly compared to PC ventilation. This neuroprotective effect appears to be linked to improved respiratory mechanics and an attenuated systemic inflammatory response. Therefore, PRVC represents a preferable ventilation strategy for this vulnerable patient population.</p>","PeriodicalId":13943,"journal":{"name":"International journal of clinical and experimental pathology","volume":"18 8","pages":"439-453"},"PeriodicalIF":0.9,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12438971/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145080558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ameloblastoma with adenoid features with multiple local recurrences: report of a case with clinicopathologic and immunohistochemical studies. 腺样特征的成釉细胞瘤伴多发局部复发:临床病理及免疫组织化学研究1例报告。
IF 0.9 Q4 ONCOLOGY Pub Date : 2025-08-15 eCollection Date: 2025-01-01 DOI: 10.62347/STIN7210
Kazuya Haraguchi, Naomi Yada, Osamu Takahashi, Izumi Yoshioka, Masaaki Sasaguri, Manabu Habu

Ameloblastoma with adenoid features is characterized by the formation of cribriform or glandular tubular structures in addition to the conventional ameloblastoma; however, many aspects of the clinical and histologic characteristics are unclear. We report a case of ameloblastoma with adenoid features that occurred in the mandible and had multiple recurrences. The patient was a 54-year-old woman who presented with a chief complaint of painless swelling in the left mandibular molar region. On the first visit, a bone expansion was noted in the lingual alveolar region of the left mandibular molar. Panoramic radiograph and computed tomography revealed a unilocular radiolucent finding extending from the left mandibular first molar to the anterior edge of the left mandibular ramus. A biopsy was performed and the diagnosis was ameloblastoma. Therefore, we performed left mandibular tumor resection. Histopathologic findings showed that tissue corresponding to the conventional ameloblastoma had proliferated, and the tumor nests had a duct-like and cribriform structure. However, no whorl/morula-like structure or dentinoid was observed, leading to a diagnosis of ameloblastoma with adenoid features. Thereafter, the tumor recurred twice, and resection surgery was performed, but both cases showed the same histopathologic findings as the initial surgery. Morphologic features are important to distinguish between ameloblastoma with adenoid features and conventional ameloblastoma. In addition, ameloblastoma with adenoid features has a stronger tendency to recur than conventional ameloblastoma, and surgical resection with a sufficient margin of safety and strict postoperative follow-up are necessary.

具有腺样特征的成釉细胞瘤除常规成釉细胞瘤外,还形成筛网状或腺管状结构;然而,临床和组织学特征的许多方面尚不清楚。我们报告一例具有腺样特征的成釉细胞瘤发生在下颌骨并多次复发。患者为54岁女性,主诉为左侧下颌磨牙区无痛性肿胀。第一次就诊时,发现左侧下颌磨牙舌牙槽区出现骨扩张。全景x光片和计算机断层扫描显示单眼透光发现从左下颌第一磨牙延伸到左下颌分支的前缘。活检后诊断为成釉细胞瘤。因此,我们进行了左侧下颌骨肿瘤切除术。组织病理学结果显示,与常规成釉细胞瘤相对应的组织增生,肿瘤巢具有管状和筛状结构。然而,没有观察到螺旋/桑葚样结构或牙本质样结构,因此诊断为具有腺样特征的成釉细胞瘤。此后,肿瘤复发两次,并进行了切除手术,但两例均显示与初次手术相同的组织病理学结果。形态学特征是区分具有腺样特征的成釉细胞瘤和普通成釉细胞瘤的重要依据。此外,具有腺样特征的成釉细胞瘤比传统的成釉细胞瘤有更强的复发倾向,有足够安全余地的手术切除和严格的术后随访是必要的。
{"title":"Ameloblastoma with adenoid features with multiple local recurrences: report of a case with clinicopathologic and immunohistochemical studies.","authors":"Kazuya Haraguchi, Naomi Yada, Osamu Takahashi, Izumi Yoshioka, Masaaki Sasaguri, Manabu Habu","doi":"10.62347/STIN7210","DOIUrl":"10.62347/STIN7210","url":null,"abstract":"<p><p>Ameloblastoma with adenoid features is characterized by the formation of cribriform or glandular tubular structures in addition to the conventional ameloblastoma; however, many aspects of the clinical and histologic characteristics are unclear. We report a case of ameloblastoma with adenoid features that occurred in the mandible and had multiple recurrences. The patient was a 54-year-old woman who presented with a chief complaint of painless swelling in the left mandibular molar region. On the first visit, a bone expansion was noted in the lingual alveolar region of the left mandibular molar. Panoramic radiograph and computed tomography revealed a unilocular radiolucent finding extending from the left mandibular first molar to the anterior edge of the left mandibular ramus. A biopsy was performed and the diagnosis was ameloblastoma. Therefore, we performed left mandibular tumor resection. Histopathologic findings showed that tissue corresponding to the conventional ameloblastoma had proliferated, and the tumor nests had a duct-like and cribriform structure. However, no whorl/morula-like structure or dentinoid was observed, leading to a diagnosis of ameloblastoma with adenoid features. Thereafter, the tumor recurred twice, and resection surgery was performed, but both cases showed the same histopathologic findings as the initial surgery. Morphologic features are important to distinguish between ameloblastoma with adenoid features and conventional ameloblastoma. In addition, ameloblastoma with adenoid features has a stronger tendency to recur than conventional ameloblastoma, and surgical resection with a sufficient margin of safety and strict postoperative follow-up are necessary.</p>","PeriodicalId":13943,"journal":{"name":"International journal of clinical and experimental pathology","volume":"18 8","pages":"464-477"},"PeriodicalIF":0.9,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12438967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145080404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repeat renal biopsy findings in 82 lupus nephritis patients: a clinicopathological study. 82例狼疮性肾炎患者重复肾活检结果:临床病理研究。
IF 0.9 Q4 ONCOLOGY Pub Date : 2025-07-15 eCollection Date: 2025-01-01 DOI: 10.62347/VFGO9374
Sixing Li, Kun Yang, Cheng Zhao, Fei Dong, Wen Zeng, Jiale Wen, Zhendong He, Wenjing Huang, Fang Qin

Objective: Lupus nephritis (LN) is among the most severe complications of systemic lupus erythematosus and is associated with increased mortality. The aim of this study was to explore the value and clinical utility of repeat renal biopsies in patients with LN.

Methods: We conducted a retrospective study of patients with biopsy-proven LN who had undergone at least two renal biopsies at First Affiliated Hospital of Guangxi Medical University from June 1, 2012 to March 31, 2024. A comparative analysis was conducted on the clinical data obtained from both renal biopsies, including demographic information, clinical manifestations, laboratory results, and pathological findings collected at the time of each biopsy. Paired sample T-test and chi-square test were used for statistical analysis.

Results: A total of 82 patients met the inclusion criteria. The male-to-female ratio of our study cohort was 1:5.83. At the first biopsy, the predominant pathological types were class IV (23.2%) and class III+V (24.4%) lupus nephritis (LN). In contrast, at the repeat biopsy, class IV (25.6%) and class IV+V (24.4%) were the most common types. Among the 82 patients included in the study, 51 (62.2%) exhibited worsening pathological types, while 24 (29.3%) showed no improvement. Compared with results obtained at the first biopsy, the prevalence of crescents increased significantly from 19.5% to 45.1%, the prevalence rates of proteinuria, pyuria, and cellular casts, as well as pathological findings of global sclerosis, tubular atrophy, interstitial fibrosis, and inflammatory cell infiltration were increased at the second biopsy (P<0.05). Estimated glomerular filtration rates were lower at the second than those at the first biopsy (P<0.05).

Conclusion: Renal biopsy should be repeated in patients with LN who have undergone treatment if urinalysis results and renal function worsen or do not improve to determine whether the pathological class of LN has changed and whether LN is in the active phase. Repeat renal biopsies show increased chronicity, the pathological types are predominantly non-remitting or worsening, with a considerable proportion of patients also presenting with crescentic glomerulonephritis. Repeat renal biopsy is necessary for the diagnosis of LN patients and may inform the design of subsequent treatment plans.

目的:狼疮肾炎(LN)是系统性红斑狼疮最严重的并发症之一,与死亡率增加有关。本研究的目的是探讨重复肾活检在LN患者中的价值和临床应用。方法:回顾性研究2012年6月1日至2024年3月31日在广西医科大学第一附属医院接受过两次以上肾活检的经活检证实的LN患者。对两组肾活检的临床资料进行比较分析,包括人口统计学信息、临床表现、实验室结果和每次活检时的病理结果。采用配对样本t检验和卡方检验进行统计分析。结果:共有82例患者符合纳入标准。本研究队列的男女比例为1:5.83。第一次活检时,主要病理类型为IV级(23.2%)和III+V级(24.4%)狼疮性肾炎(LN)。相比之下,在重复活检中,IV型(25.6%)和IV+V型(24.4%)是最常见的类型。纳入研究的82例患者中,51例(62.2%)病理类型恶化,24例(29.3%)无改善。与第一次活检结果相比,新月状病变的患病率从19.5%显著上升至45.1%,蛋白尿、脓尿、细胞型铸造的患病率,以及全球硬化症、小管萎缩、间质纤维化和炎症细胞浸润的病理表现在第二次活检中有所增加(p)。对于接受过治疗的LN患者,如果尿液分析结果和肾功能恶化或没有改善,应重复进行肾活检,以确定LN的病理类型是否发生变化以及LN是否处于活动期。重复肾活检显示慢性加重,病理类型以不缓解或恶化为主,相当比例的患者还表现为新月形肾小球肾炎。重复肾活检对于LN患者的诊断是必要的,并且可以为后续治疗计划的设计提供信息。
{"title":"Repeat renal biopsy findings in 82 lupus nephritis patients: a clinicopathological study.","authors":"Sixing Li, Kun Yang, Cheng Zhao, Fei Dong, Wen Zeng, Jiale Wen, Zhendong He, Wenjing Huang, Fang Qin","doi":"10.62347/VFGO9374","DOIUrl":"10.62347/VFGO9374","url":null,"abstract":"<p><strong>Objective: </strong>Lupus nephritis (LN) is among the most severe complications of systemic lupus erythematosus and is associated with increased mortality. The aim of this study was to explore the value and clinical utility of repeat renal biopsies in patients with LN.</p><p><strong>Methods: </strong>We conducted a retrospective study of patients with biopsy-proven LN who had undergone at least two renal biopsies at First Affiliated Hospital of Guangxi Medical University from June 1, 2012 to March 31, 2024. A comparative analysis was conducted on the clinical data obtained from both renal biopsies, including demographic information, clinical manifestations, laboratory results, and pathological findings collected at the time of each biopsy. Paired sample T-test and chi-square test were used for statistical analysis.</p><p><strong>Results: </strong>A total of 82 patients met the inclusion criteria. The male-to-female ratio of our study cohort was 1:5.83. At the first biopsy, the predominant pathological types were class IV (23.2%) and class III+V (24.4%) lupus nephritis (LN). In contrast, at the repeat biopsy, class IV (25.6%) and class IV+V (24.4%) were the most common types. Among the 82 patients included in the study, 51 (62.2%) exhibited worsening pathological types, while 24 (29.3%) showed no improvement. Compared with results obtained at the first biopsy, the prevalence of crescents increased significantly from 19.5% to 45.1%, the prevalence rates of proteinuria, pyuria, and cellular casts, as well as pathological findings of global sclerosis, tubular atrophy, interstitial fibrosis, and inflammatory cell infiltration were increased at the second biopsy (P<0.05). Estimated glomerular filtration rates were lower at the second than those at the first biopsy (P<0.05).</p><p><strong>Conclusion: </strong>Renal biopsy should be repeated in patients with LN who have undergone treatment if urinalysis results and renal function worsen or do not improve to determine whether the pathological class of LN has changed and whether LN is in the active phase. Repeat renal biopsies show increased chronicity, the pathological types are predominantly non-remitting or worsening, with a considerable proportion of patients also presenting with crescentic glomerulonephritis. Repeat renal biopsy is necessary for the diagnosis of LN patients and may inform the design of subsequent treatment plans.</p>","PeriodicalId":13943,"journal":{"name":"International journal of clinical and experimental pathology","volume":"18 7","pages":"364-374"},"PeriodicalIF":0.9,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144855142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lactobacillus-based probiotic cocktail inhibits colitis-associated cancer by altering intestinal metabolism. 以乳酸杆菌为基础的益生菌鸡尾酒通过改变肠道代谢抑制结肠炎相关的癌症。
IF 0.9 Q4 ONCOLOGY Pub Date : 2025-07-15 eCollection Date: 2025-01-01 DOI: 10.62347/USLL6631
Weiyi Wang, Ying Xu, Yimin Chu, Haiqin Zhang, Lu Zhou, Haijin Zhu, Ji Li, Zixu Zhang, Jinnian Cheng, Fengli Zhou, Daming Yang, Weisong Xu, Haixia Peng

Objective: Dysbiosis of intestinal microbiome is an important colorectal cancer (CRC) pathogenetic mechanism. Lactobacillus-based probiotic cocktail could inhibit colitis-associated cancer (CAC) by alleviating intestinal dysbiosis. The intestinal microbial metabolites have been linked with CRC etiology. However, the link between Lactobacillus-based probiotic cocktail and the alteration of intestinal metabolism and their functional mechanisms during CAC process is still poorly understood.

Methods: For assessing protective effects of the probiotic cocktail, azomethanes/dextran sodium sulfate (AOM/DSS) induced CAC mice were pretreated with the probiotic cocktail. Colon of C57BL/6 mice were used to assess inflammation and tumorigenesis. Comparative analysis was performed for determining how the probiotic altered intestinal metabolism and gene expression. Meanwhile, intestinal microbiota alterations were analyzed. The concluding integrated analysis of intestinal metabolism and gene expression as well as intestinal microbiota was presented.

Results: Pretreatment with the probiotic alleviated intestinal inflammation and limited the formation of tumors. Oncogenes were down-regulated and cancer suppressor genes were up-regulated after probiotic pretreatment. Pretreatment with the probiotic induced a rise of Lactobacillus-dominated genera and a reduction of potential pathogenic bacteria Parasutterella, Helicobacter and Muribaculum, and affected expression of intestinal metabolites that involved 37 metabolic pathways. Lactobacillus-associated intestinal metabolite variations involve five metabolic pathways - arginine and proline metabolism, histidine metabolism, pyrimidine metabolism, purine metabolism, and tyrosine metabolism.

Conclusions: Pretreatment with Lactobacillus-based probiotic cocktail protected mice from CAC by interfering with intestinal metabolites that affected the cancer suppressor genes and oncogenes' expression. Furthermore, Lactobacillus affected five metabolite pathways, which was important mechanism for probiotic anti-inflammatory and anti-tumorigenesis.

目的:肠道菌群失调是结直肠癌的重要发病机制。以乳酸杆菌为基础的益生菌鸡尾酒可通过缓解肠道生态失调来抑制结肠炎相关癌(CAC)。肠道微生物代谢物与结直肠癌的病因有关。然而,在CAC过程中,以乳酸杆菌为基础的益生菌鸡尾酒与肠道代谢改变之间的联系及其功能机制尚不清楚。方法:以偶氮甲烷/葡聚糖硫酸钠(AOM/DSS)诱导的CAC小鼠为研究对象,采用益生菌混合物预处理CAC小鼠,观察其保护作用。用C57BL/6小鼠结肠评估炎症和肿瘤发生。通过比较分析确定益生菌如何改变肠道代谢和基因表达。同时,分析肠道菌群变化。最后对肠道代谢、基因表达及肠道菌群进行综合分析。结果:益生菌预处理可减轻肠道炎症,抑制肿瘤的形成。益生菌预处理后,癌基因下调,抑癌基因上调。益生菌预处理诱导以乳酸杆菌为主的菌属增加,潜在致病菌Parasutterella、Helicobacter和Muribaculum减少,并影响涉及37种代谢途径的肠道代谢物的表达。乳酸杆菌相关的肠道代谢物变化涉及5种代谢途径——精氨酸和脯氨酸代谢、组氨酸代谢、嘧啶代谢、嘌呤代谢和酪氨酸代谢。结论:以乳酸杆菌为基础的益生菌鸡尾酒预处理通过干扰影响抑癌基因和癌基因表达的肠道代谢物来保护小鼠CAC。此外,乳杆菌影响了5种代谢途径,这是益生菌抗炎和抗肿瘤的重要机制。
{"title":"Lactobacillus-based probiotic cocktail inhibits colitis-associated cancer by altering intestinal metabolism.","authors":"Weiyi Wang, Ying Xu, Yimin Chu, Haiqin Zhang, Lu Zhou, Haijin Zhu, Ji Li, Zixu Zhang, Jinnian Cheng, Fengli Zhou, Daming Yang, Weisong Xu, Haixia Peng","doi":"10.62347/USLL6631","DOIUrl":"10.62347/USLL6631","url":null,"abstract":"<p><strong>Objective: </strong>Dysbiosis of intestinal microbiome is an important colorectal cancer (CRC) pathogenetic mechanism. Lactobacillus-based probiotic cocktail could inhibit colitis-associated cancer (CAC) by alleviating intestinal dysbiosis. The intestinal microbial metabolites have been linked with CRC etiology. However, the link between Lactobacillus-based probiotic cocktail and the alteration of intestinal metabolism and their functional mechanisms during CAC process is still poorly understood.</p><p><strong>Methods: </strong>For assessing protective effects of the probiotic cocktail, azomethanes/dextran sodium sulfate (AOM/DSS) induced CAC mice were pretreated with the probiotic cocktail. Colon of C57BL/6 mice were used to assess inflammation and tumorigenesis. Comparative analysis was performed for determining how the probiotic altered intestinal metabolism and gene expression. Meanwhile, intestinal microbiota alterations were analyzed. The concluding integrated analysis of intestinal metabolism and gene expression as well as intestinal microbiota was presented.</p><p><strong>Results: </strong>Pretreatment with the probiotic alleviated intestinal inflammation and limited the formation of tumors. Oncogenes were down-regulated and cancer suppressor genes were up-regulated after probiotic pretreatment. Pretreatment with the probiotic induced a rise of Lactobacillus-dominated genera and a reduction of potential pathogenic bacteria Parasutterella, Helicobacter and Muribaculum, and affected expression of intestinal metabolites that involved 37 metabolic pathways. Lactobacillus-associated intestinal metabolite variations involve five metabolic pathways - arginine and proline metabolism, histidine metabolism, pyrimidine metabolism, purine metabolism, and tyrosine metabolism.</p><p><strong>Conclusions: </strong>Pretreatment with Lactobacillus-based probiotic cocktail protected mice from CAC by interfering with intestinal metabolites that affected the cancer suppressor genes and oncogenes' expression. Furthermore, Lactobacillus affected five metabolite pathways, which was important mechanism for probiotic anti-inflammatory and anti-tumorigenesis.</p>","PeriodicalId":13943,"journal":{"name":"International journal of clinical and experimental pathology","volume":"18 7","pages":"317-334"},"PeriodicalIF":0.9,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12343454/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144855140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of clinical and experimental pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1